Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $204B
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Quarter Return
+14.82%
1 Year Return
+26.64%
3 Year Return
+125.28%
5 Year Return
+196.8%
10 Year Return
+578.78%
AUM
$183B
AUM Growth
+$183B
Cap. Flow
-$2.35B
Cap. Flow %
-1.28%
Top 10 Hldgs %
28.42%
Holding
2,613
New
67
Increased
1,360
Reduced
899
Closed
85

Sector Composition

1 Technology 32.99%
2 Healthcare 19.05%
3 Consumer Discretionary 10.13%
4 Financials 9.7%
5 Industrials 9.36%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VOO icon
176
Vanguard S&P 500 ETF
VOO
$724B
$225M 0.12%
467,416
-11,419
-2% -$5.49M
COR icon
177
Cencora
COR
$57.2B
$224M 0.12%
921,755
+117,888
+15% +$28.6M
AVDL
178
Avadel Pharmaceuticals
AVDL
$1.42B
$218M 0.12%
12,915,160
+1,789,830
+16% +$30.2M
PLD icon
179
Prologis
PLD
$103B
$217M 0.12%
1,664,336
-463,624
-22% -$60.4M
BLKB icon
180
Blackbaud
BLKB
$3.23B
$211M 0.11%
2,840,576
+53,057
+2% +$3.93M
ELV icon
181
Elevance Health
ELV
$72.4B
$210M 0.11%
405,094
-14,138
-3% -$7.33M
ZD icon
182
Ziff Davis
ZD
$1.53B
$204M 0.11%
3,239,654
+10,303
+0.3% +$650K
WD icon
183
Walker & Dunlop
WD
$2.79B
$202M 0.11%
1,998,145
-34,145
-2% -$3.45M
APO icon
184
Apollo Global Management
APO
$75.9B
$199M 0.11%
1,772,486
-10,181
-0.6% -$1.14M
CRM icon
185
Salesforce
CRM
$245B
$195M 0.11%
648,753
+21,298
+3% +$6.41M
APG icon
186
APi Group
APG
$14.4B
$192M 0.1%
4,884,712
+4,808,536
+6,312% +$189M
NBIX icon
187
Neurocrine Biosciences
NBIX
$13.5B
$190M 0.1%
1,378,513
-172,854
-11% -$23.8M
XYL icon
188
Xylem
XYL
$34B
$188M 0.1%
1,456,290
-12,670
-0.9% -$1.64M
ALIT icon
189
Alight
ALIT
$2.07B
$188M 0.1%
19,060,481
+331,303
+2% +$3.26M
SRE icon
190
Sempra
SRE
$53.7B
$188M 0.1%
2,610,647
-662,028
-20% -$47.6M
KEYS icon
191
Keysight
KEYS
$28.4B
$185M 0.1%
1,180,836
-342,021
-22% -$53.5M
OXY icon
192
Occidental Petroleum
OXY
$45.6B
$184M 0.1%
2,838,767
-242,636
-8% -$15.8M
DLTR icon
193
Dollar Tree
DLTR
$21.3B
$182M 0.1%
1,363,426
-6,357
-0.5% -$846K
GTLS icon
194
Chart Industries
GTLS
$8.94B
$181M 0.1%
1,099,953
+31,553
+3% +$5.2M
COF icon
195
Capital One
COF
$142B
$181M 0.1%
1,216,724
+5,473
+0.5% +$815K
SHC icon
196
Sotera Health
SHC
$4.54B
$179M 0.1%
14,892,868
+4,525,056
+44% +$54.3M
OSIS icon
197
OSI Systems
OSIS
$3.92B
$179M 0.1%
1,249,889
+19,683
+2% +$2.81M
RYAN icon
198
Ryan Specialty Holdings
RYAN
$7.04B
$172M 0.09%
3,095,804
-8,112
-0.3% -$450K
NVO icon
199
Novo Nordisk
NVO
$252B
$169M 0.09%
1,317,710
-251,854
-16% -$32.3M
IDYA icon
200
IDEAYA Biosciences
IDYA
$2.26B
$167M 0.09%
3,808,450
+256,559
+7% +$11.3M